Applied DNA Gets Contract from HDT Bio for Vaccine Development
Applied DNA gets contract from HDT Bio for vaccine development under a ‘Project NextGen: Enabler’
Overview
Applied DNA Sciences, Inc. (Applied DNA), a leader in PCR-based DNA technologies, announced the award of a contract from HDT Bio for the purpose of rapid, next-generation vaccine development under a ‘Project NextGen: Enabler’ award to HDT Bio (the “Project”). The Project seeks to facilitate the rapid production of vaccines during outbreaks/pandemics, focusing on decentralized vaccine manufacturing, with vaccines deemed critical medical countermeasures to infectious disease threats.
Terms of The Contract
Under the terms of the contract, Applied DNA will supply Linea DNA IVT templates to HDT Bio for use in conjunction with its LION formulated repRNA (self-replicating RNA) vaccination platform.
The goal of the contract is to demonstrate the feasibility of manufacturing 1,000 doses of a functional vaccine within seven days.
Linea DNA Platform
The Linea DNA platform is a completely cell-free DNA production platform founded on Applied DNA's long-standing expertise in the large-scale enzymatic production of DNA.
Capable of producing DNA in quantities ranging from milligrams to grams, the Linea DNA platform can produce high-fidelity DNA constructs ranging from 100bp to 20kb in size.
The DNA produced via the Linea DNA platform is free of the adventitious DNA sequences found in other sources of DNA, is rapidly scalable, and provides for simple chemical modification of DNA constructs.
Linea IVT Platform
The Linea IVT platform combines DNA IVT templates manufacturing via the Linea DNA platform with a proprietary Linea RNAP to enable mRNA and sa-mRNA manufacturers to produce what Applied DNA believes to be better mRNA faster, with advantages over conventional
mRNA production, including:
1) the elimination of plasmid DNA as a starting material;
2) the prevention or reduction of double-stranded DNA (dsRNA) contamination; and
3) simplified mRNA production workflows.
HDT Bio
HDT Bio is a Seattle-based, clinical-stage biopharmaceutical development company.
With core technology and expertise in nucleic acid formulation, the company develops products that seek to harness host-directed immune responses.
Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid (DNA).
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!